9.23
2.33%
0.21
Handel nachbörslich:
9.25
0.02
+0.22%
Finanzdaten der Corvus Pharmaceuticals Inc-Aktie (CRVS)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
-
|
- | - | - | - |
Operating Expenses
|
10.65%
6.253
|
5.651 | 5.56 | 5.622 | 6.574 |
Depreciation and Amortization |
70.13%
0.023
|
0.077 | 0.03 | 0.036 | 0.057 |
Operating Income/Loss |
10.65%
-6.253
|
-5.651 | -5.56 | -5.622 | -6.574 |
Income/Loss Before Equity Method Investments |
-5.937
|
- | - | - | - |
Income/Loss From Continuing Operations Before Tax |
10.76%
-5.937
|
-6.653 | -6.00 | -6.503 | -7.873 |
Income Tax Expense/Benefit |
-
|
- | - | - | - |
Income/Loss From Continuing Operations After Tax |
10.76%
-5.937
|
-6.653 | -6.00 | -6.503 | -7.873 |
Net Income/Loss
|
14.31%
-5.701
|
-6.653 | -6.00 | -6.503 | -7.873 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
14,261%
49.04
|
0.3415 | 48.97 | 47.50 | 46.56 |
Diluted Average Shares |
14,261%
49.04
|
0.3415 | 48.97 | 47.50 | 46.56 |
Basic Earnings Per Share |
7.69%
-0.12
|
-0.13 | -0.12 | -0.14 | -0.17 |
Diluted Earnings Per Share |
7.69%
-0.12
|
-0.13 | -0.12 | -0.14 | -0.17 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):